• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Trupanion Inc.

    4/30/25 4:09:51 PM ET
    $TRUP
    Medical Specialities
    Health Care
    Get the next $TRUP alert in real time by email
    DEFA14A 1 d905089ddefa14a.htm DEFA14A DEFA14A
     
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 14A

    (Rule 14a-101)

     

     

    SCHEDULE 14A INFORMATION

    Proxy Statement Pursuant to Section 14(a) of

    the Securities Exchange Act of 1934

     

     

    Filed by the Registrant ☒

    Filed by a Party other than the Registrant ☐

    Check the appropriate box:

     

    ☐

    Preliminary Proxy Statement

     

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ☐

    Definitive Proxy Statement

     

    ☒

    Definitive Additional Materials

     

    ☐

    Soliciting Material Pursuant to §240.14a-12

    TRUPANION, INC.

    (Name of Registrant as Specified In Its Charter)

    Payment of Filing Fee (Check the appropriate box):

     

    ☒

    No fee required.

     

    ☐

    Fee paid previously with preliminary materials.

     

    ☐

    Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

     

     
     


    LOGO

    C/O BROADRIDGE CORPORATE ISSUER SOLUTIONS, INC. P O BOX 1342 BRENTWOOD, NY 11717 V70104-P28701 Your Vote Counts! TRUPANION, INC. 2025 Annual Meeting Vote by June 10, 2025 11:59 PM ET You invested in TRUPANION, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the stockholder meeting to be held on June 11, 2025. Get informed before you vote View the Notice and Proxy Statement and Annual Report/10-K online OR you can receive a free paper or email copy of the material(s) by requesting prior to May 28, 2025. If you would like to request a copy of the material(s) for this and/or future stockholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to [email protected]. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. For complete information and to vote, visit www.ProxyVote.com Control # Smartphone users Point your camera here and vote without entering a control number Vote in Person at the Meeting* June 11, 2025 9:00 AM PDT Trupanion, Inc. 6100 4th Avenue South Seattle, WA 98108 *Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you will need to request a ballot to vote these shares.


    LOGO

    Vote at www.ProxyVote.com THIS IS NOT A VOTABLE BALLOT This is an overview of the proposals being presented at the upcoming stockholder meeting. Please follow the instructions on the reverse side to vote these important matters. Board Voting Items Recommends 1. To elect nine directors to hold office until our 2026 Annual Meeting of Stockholders. Nominees: 1a. Max Brodén For 1b. Jacqueline Davidson For 1c. Paulette Dodson For 1d. Richard Enthoven For 1e. Murray Low For 1f. Elizabeth McLaughlin For 1g. Darryl Rawlings For 1h. Howard Rubin For 1i. Margaret Tooth For 2. To ratify the selection of Ernst & Young LLP as Trupanion, Inc.’s independent registered public accounting firm for the For fiscal year ending December 31, 2025. 3. To approve, by non-binding advisory vote, the compensation of our named executive officers for the year ended For December 31, 2024. 4. To approve, by non-binding advisory vote, the frequency of future advisory votes on the compensation of our named 1 Year executive officers. NOTE: Such other business as may properly come before the meeting or any adjournment thereof. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. V70105-P28701

    Get the next $TRUP alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TRUP

    DatePrice TargetRatingAnalyst
    8/13/2025$47.00Neutral
    Cantor Fitzgerald
    1/23/2025$57.00Neutral → Overweight
    Piper Sandler
    7/19/2024Outperform
    William Blair
    5/16/2024$35.00 → $49.00Neutral → Buy
    BofA Securities
    5/8/2023$72.00 → $32.00Buy → Neutral
    BofA Securities
    9/21/2022$77.00Buy
    Jefferies
    8/4/2022$80.00 → $69.00Overweight → Neutral
    Piper Sandler
    2/24/2022$129.00 → $118.00Neutral → Buy
    B of A Securities
    More analyst ratings

    $TRUP
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Revenue Officer Dreyer Emily

    4 - TRUPANION, INC. (0001371285) (Issuer)

    8/19/25 4:48:55 PM ET
    $TRUP
    Medical Specialities
    Health Care

    CEO Tooth Margaret exercised 200 shares at a strike of $7.78 and sold $9,714 worth of shares (200 units at $48.57) (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    6/10/25 4:40:19 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Chief Financial Officer Qureshi Fawwad sold $122,406 worth of shares (2,534 units at $48.31), decreasing direct ownership by 42% to 3,545 units (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    6/2/25 7:47:35 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4) (Amendment)

    4/A - TRUPANION, INC. (0001371285) (Issuer)

    5/15/24 7:27:19 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Rawlings Darryl bought $499,663 worth of shares (20,700 units at $24.14), increasing direct ownership by 3% to 614,842 units (SEC Form 4)

    4 - TRUPANION, INC. (0001371285) (Issuer)

    5/9/24 6:40:58 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Trupanion Inc.

    SCHEDULE 13G/A - TRUPANION, INC. (0001371285) (Subject)

    8/12/25 10:34:26 AM ET
    $TRUP
    Medical Specialities
    Health Care

    SEC Form 10-Q filed by Trupanion Inc.

    10-Q - TRUPANION, INC. (0001371285) (Filer)

    8/7/25 5:11:38 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TRUPANION, INC. (0001371285) (Filer)

    8/7/25 4:02:40 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Trupanion Reports Second Quarter 2025 Results

    SEATTLE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended June 30, 2025. "The second quarter was one of the strongest financial quarters in our history, marked by consistent top-line growth, robust margin expansion and strengthening retention," said Margi Tooth, Chief Executive Officer and President of Trupanion. "These results create a strong foundation to invest in this globally underpenetrated market and bring the benefits of Trupanion to more pets and pet parents." Second Quarter 2025 Financial and Business Highlights T

    8/7/25 4:05:50 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion to Participate in the Canaccord Genuity 45th Annual Growth Conference

    SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today that Margi Tooth, Chief Executive Officer and President, will participate in a fireside chat at the Canaccord Genuity 45th Annual Growth Conference in Boston, Massachusetts on Wednesday, August 13, 2025 at 9:30 a.m. ET and will participate in meetings with investors throughout the day. The presentation will be webcast live and can be accessed on Trupanion's Investor Relations website at http://investors.trupanion.com. About Trupanion Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, and certain countri

    7/31/25 4:30:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion Announces Second Quarter 2025 Earnings Release and Conference Call

    SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 second quarter after the market closes on Thursday, August 7, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can a

    7/17/25 4:15:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Trupanion with a new price target

    Cantor Fitzgerald initiated coverage of Trupanion with a rating of Neutral and set a new price target of $47.00

    8/13/25 8:15:02 AM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Trupanion from Neutral to Overweight and set a new price target of $57.00

    1/23/25 7:55:01 AM ET
    $TRUP
    Medical Specialities
    Health Care

    William Blair initiated coverage on Trupanion

    William Blair initiated coverage of Trupanion with a rating of Outperform

    7/19/24 7:44:19 AM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Financials

    Live finance-specific insights

    View All

    Trupanion Reports Second Quarter 2025 Results

    SEATTLE, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the second quarter ended June 30, 2025. "The second quarter was one of the strongest financial quarters in our history, marked by consistent top-line growth, robust margin expansion and strengthening retention," said Margi Tooth, Chief Executive Officer and President of Trupanion. "These results create a strong foundation to invest in this globally underpenetrated market and bring the benefits of Trupanion to more pets and pet parents." Second Quarter 2025 Financial and Business Highlights T

    8/7/25 4:05:50 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion Announces Second Quarter 2025 Earnings Release and Conference Call

    SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leader in medical insurance for cats and dogs, announced today it will report financial results for its 2025 second quarter after the market closes on Thursday, August 7, 2025. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast discussing results, guidance and management observations will be available on Trupanion's Investor Relations site under Investor Events at http://investors.trupanion.com and will be archived online for 3 months upon completion of the conference call. A slide presentation will also be available on the site. Participants can a

    7/17/25 4:15:00 PM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion Reports First Quarter 2025 Results

    SEATTLE, May 01, 2025 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2025. "Q1 was a strong start to the year, with performance ahead of plan across key metrics," said Margi Tooth, Chief Executive Officer and President of Trupanion. "We saw early momentum in both retention and pet acquisition, and with expanded margins in our subscription business, we're well-positioned to continue to invest in growth." First Quarter 2025 Financial and Business Highlights Total revenue was $342.0 million, an increase of 12% compared to the first quarter of 2024.Total e

    5/1/25 4:05:07 PM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Trupanion Inc.

    SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

    11/8/24 10:46:38 AM ET
    $TRUP
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

    SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

    4/5/24 4:09:50 PM ET
    $TRUP
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Trupanion Inc. (Amendment)

    SC 13G/A - TRUPANION, INC. (0001371285) (Subject)

    2/12/24 11:02:49 AM ET
    $TRUP
    Medical Specialities
    Health Care

    $TRUP
    Leadership Updates

    Live Leadership Updates

    View All

    Grindr Appoints Veteran Public Company CFO and Audit Committee Chair Chad Cohen to Board of Directors

    Cohen to serve as Chair of the Audit Committee Grindr Inc. (NYSE:GRND), the Global Gayborhood in Your Pocket™, today announced the appointment of Chad Cohen, former Chief Financial Officer of Zillow Group Inc. (NASDAQ:Z) and Adaptive Biotechnologies Corp. (NASDAQ:ADPT) and Founding Partner of Scala Advisors, LLC, to Grindr's Board of Directors as of June 3, 2025. Cohen was also appointed to serve as the Chair of Grindr's Audit Committee. A seasoned public company finance executive and board member, Cohen has helped grow several multi-billion dollar technology companies, including multiple leading consumer Internet brands. Prior to his current role, Cohen served as the Chief Financial Of

    6/3/25 4:05:00 PM ET
    $ADPT
    $GRND
    $TRUP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Computer Software: Programming Data Processing
    Technology

    Trupanion Partners with Leading Pet and Public Health Authorities to Launch Pet & Public Health Early Warning and Detection System

    Boehringer Ingelheim, Mars Science & Diagnostics and leading pet, public health and animal health authorities to join Advisory Board Collaboration to address emerging pet and public health threats to protect pets and peopleEarly detection potential has global pet and public health benefits  SEATTLE, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), the leading provider of medical insurance for cats and dogs in North America, in partnership with the Centers for Disease Control and Prevention (CDC), and leading pet industry partners, today announced the formation of a collaborative Advisory Board to launch a Pet & Public Health Early Warning & Detection System. The Advisory B

    8/14/24 9:00:00 AM ET
    $TRUP
    Medical Specialities
    Health Care

    Trupanion's Margi Tooth Appointed Chief Executive Officer Effective August 1, 2024

    SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (NASDAQ:TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth's appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also continue as President and hold the dual titles of CEO and President. Additionally, Tooth is anticipated to be appointed to Trupanion's Board of Directors during its July meeting. Trupanion's founder and outgoing CEO Darryl Rawlings will continue to serve in the role of Chair of the Board, in which capacity he

    5/2/24 4:04:29 PM ET
    $TRUP
    Medical Specialities
    Health Care